Continuous Glucose Monitoring Market Report 2026

Continuous Glucose Monitoring Market Overview

• Continuous Glucose Monitoring market size has reached to $9.44 billion in 2025 • Expected to grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 14.8% • Growth Driver: The Rise In Diabetes Cases Driving The Growth Of The Continuous Glucose Monitoring Market Due To Increasing Demand For Real-Time Blood Sugar Management • Market Trend: Innovation In The Market With Revolutionary Sensor Tracks Glucose In Real Time For Smarter Health Decisions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Continuous Glucose Monitoring Market?

Continuous glucose monitoring (CGM) is a medical technology that tracks glucose levels in real time throughout the day and night using a small sensor inserted under the skin. It helps individuals with diabetes manage their condition by providing continuous data and alerts for high or low blood sugar levels. The main components of continuous glucose monitoring systems are transmitters, sensors, and receivers. Transmitters are devices that send signals, such as radio waves or electrical impulses, from one location to another for communication or control purposes. These systems are used by both adults and children, and they serve a variety of end users, including hospitals, home care settings, diagnostic centers, clinics, and other healthcare facilities.

What Is The Continuous Glucose Monitoring Market Growth Forecast?

The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $18.86 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to advancement in implantable and wearable sensors, integration with mobile health and telemedicine platforms, rising prevalence of diabetes globally, development of non-invasive glucose monitoring technology, expansion of home healthcare and remote patient monitoring services. Major trends in the forecast period include growing adoption of continuous glucose monitoring devices among diabetic patients, development of minimally invasive and implantable sensors, integration of real-time data analytics and alert systems, expansion of home-based monitoring and telehealth solutions, rising demand for pediatric and geriatric glucose monitoring solutions.

Global Continuous Glucose Monitoring Market Segmentation

1) By Component: Transmitters, Sensors, Receivers 2) By Age Group: Adults, Children 3) By End Use: Hospitals, Home Care Settings, Diagnostic Centers And Clinics, Other End Uses Subsegments: 1) By Transmitters: Reusable Transmitters, Disposable Transmitters, Rechargeable Transmitters 2) By Sensors: Implantable Sensors, Transcutaneous Sensors, Disposable Sensors, Real-Time Sensors 3) By Receivers: Standalone Receivers, Integrated Receivers, Wearable Display Devices

What Is The Driver Of The Continuous Glucose Monitoring Market?

The rising prevalence of diabetes is expected to propel the growth of the continuous glucose monitoring market going forward. Diabetes is a chronic medical condition in which the body either does not produce enough insulin or cannot effectively use the insulin it produces, resulting in high levels of sugar (glucose) in the blood. The rising prevalence of diabetes is primarily due to unhealthy diets high in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring helps diabetes management by providing real-time blood sugar trends, enabling timely decisions on diet, medication, and activity to maintain better glucose control. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of diabetes is driving the growth of the continuous glucose monitoring industry.

Key Players In The Global Continuous Glucose Monitoring Market

Major companies operating in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Dexcom Inc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Bionime Corporation, Biolinq Inc, Beta Bionics Inc, AgaMatrix Inc, A Menarini Diagnostics SRL, Senseonics Holdings Inc, Medtrum Technologies Inc, Nemaura Medical Inc, LifeScan Inc, EOFlow Co Ltd, POCTech Co Ltd

Global Continuous Glucose Monitoring Market Trends and Insights

Major companies operating in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to enhance accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors are devices that continuously measure blood sugar levels using a small sensor placed under the skin. For instance, in August 2024, DexCom, Inc., a US-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings through a small sensor worn on the back of the upper arm, with data sent directly to a smartphone no prescription or fingersticks needed. The device offers personalized insights and trend analysis, helping users understand how factors like diet, exercise, and sleep impact their glucose levels, enabling smarter lifestyle choices. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not on insulin, those with prediabetes, or anyone monitoring their glucose health.

What Are Latest Mergers And Acquisitions In The Continuous Glucose Monitoring Market?

In September 2023, Abbott Laboratories, a US-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. With this acquisition, Abbott aims to expand its presence in diabetes care by building on its freestyle Libre continuous glucose monitoring technology and further developing connected solutions to make diabetes management more personal and precise. Bigfoot Biomedical Inc. is a US-based medical technology company that offers a diabetes management system that integrates continuous glucose monitoring (CGM) technology.

Regional Outlook

North America was the largest region in the continuous glucose monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Continuous Glucose Monitoring Market?

The continuous glucose monitoring market consists of revenues earned by entities by providing services such as real-time glucose tracking, remote patient monitoring, and data analytics for personalized diabetes management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring market also includes sales of Integrated insulin pumps, mobile and wearable apps and cloud-based data management platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.